Roger J. Chin

  • Partner
  • 505 Montgomery Street
  • Suite 2000
  • San Francisco, CA 94111-6538
  • USA
  • T +1.415.395.8122


Dr. Roger J. Chin is a partner in the San Francisco office of Latham & Watkins and a member of the firm’s Litigation & Trial Department. For more than two decades he has handled life science patent disputes and advised on intellectual property strategy in the pharmaceutical, biotechnology, and medical device industries. He also has experience advising clients on Hatch-Waxman litigation, regulatory exclusivities, and FDA citizen petitions.

Dr. Chin has successfully represented clients in patent cases through preliminary injunction motions, summary judgment, trial, and appeal. He has litigated technology in areas such as chemistry, pharmaceutics, medicine, molecular biology, and genomics. Dr. Chin has been recognized as a Life Sciences Star by LMG Life Sciences and a Top Rated Intellectual Property Litigation Attorney by Super Lawyers.

Dr. Chin received his JD from Yale Law School, his MD from Yale Medical School, and his AB summa cum laude in Chemistry from Cornell University. He is admitted to practice law before the Supreme Court of California, the US Courts of Appeal for the Federal and Ninth Circuits, and various US District Courts.


Dr. Chin’s representative matters include:

  • Represented a molecular diagnostics company in patent infringement and inventorship litigation involving DNA microarray technology. Successfully argued claim construction, which resulted in summary judgment of noninfringement that was affirmed on appeal.
  • Represented a manufacturer of laser surgery equipment in patent infringement and inventorship disputes spanning over a decade. Successfully argued a precedential appeal that established laches as a defense to correction of inventorship.
  • Represented pharmaceutical companies in a number of patent cases involving multi-billion dollar products, including patent infringement disputes on marketed pharmaceutical products and litigation under the Hatch-Waxman Act.
  • Represented a biotechnology company in multiple patent disputes involving DNA sequencing technology.
  • Represented a manufacturer of tissue-based diagnostic instruments in patent litigation across multiple federal district courts and two international arbitration tribunals.
  • Represented various clients in international patent litigation, including coordination of patent disputes in the UK High Court of Justice, the German Federal Patent Court, and the European Patent Office.
Bar Qualification
  • California
  • MD, Yale Medical School, 1996
  • JD, Yale Law School, 1995
  • AB in Chemistry, Cornell University, 1990
  • Healthcare & Life Sciences
  • Intellectual Property Litigation
  • Litigation & Trial Practice